Many approved PI3K/AKT/mTOR pathway targeting compounds can suppress proliferation and induce apoptosis, which suggests that inhibition of PI3K/AKT/mTOR pathway could achieve good treatment for GC.10–14. Here, AKT1 is linked to gastric cancer.